These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36265088)

  • 21. Cost-Effectiveness of an Ultrasound-First Strategy in the Diagnostic Evaluation of Noncalcified Lesions Recalled From Screening Digital Breast Tomosynthesis.
    Ozcan BB; Xi Y; Dogan BE; Porembka JH
    AJR Am J Roentgenol; 2024 Oct; 223(4):e2431422. PubMed ID: 39082850
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
    Wong FL; Bhatia S; Landier W; Francisco L; Leisenring W; Hudson MM; Armstrong GT; Mertens A; Stovall M; Robison LL; Lyman GH; Lipshultz SE; Armenian SH
    Ann Intern Med; 2014 May; 160(10):672-83. PubMed ID: 24842414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
    Cott Chubiz JE; Lee JM; Gilmore ME; Kong CY; Lowry KP; Halpern EF; McMahon PM; Ryan PD; Gazelle GS
    Cancer; 2013 Mar; 119(6):1266-76. PubMed ID: 23184400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
    Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
    J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
    Ykema BLM; Gini A; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; de Boer JP; Verbeek WHM; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; ; Aleman BMP; Meijer GA; van Leeuwen FE; Snaebjornsson P; Carvalho B; van Leerdam ME; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2157-2168. PubMed ID: 36166472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging.
    Tieu MT; Cigsar C; Ahmed S; Ng A; Diller L; Millar BA; Crystal P; Hodgson DC
    Cancer; 2014 Aug; 120(16):2507-13. PubMed ID: 24888639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the Benefits and Cost-Effectiveness of Population-Based Breast Cancer Screening in Urban China: A Model-Based Analysis.
    Wang J; Greuter MJW; Zheng S; van Veldhuizen DWA; Vermeulen KM; Wang Y; Lu W; de Bock GH
    Int J Health Policy Manag; 2022 Sep; 11(9):1658-1667. PubMed ID: 34273933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer.
    Tollens F; Baltzer PAT; Dietzel M; Schnitzer ML; Schwarze V; Kunz WG; Rink J; Rübenthaler J; Froelich MF; Schönberg SO; Kaiser CG
    Eur Radiol; 2022 Nov; 32(11):7409-7419. PubMed ID: 35482122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
    Lee JM; McMahon PM; Kong CY; Kopans DB; Ryan PD; Ozanne EM; Halpern EF; Gazelle GS
    Radiology; 2010 Mar; 254(3):793-800. PubMed ID: 20177093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
    Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
    JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
    Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
    Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.
    Chen AB; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2009 Nov; 27(32):5383-9. PubMed ID: 19752333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.
    Kregting LM; Sankatsing VDV; Heijnsdijk EAM; de Koning HJ; van Ravesteyn NT
    Int J Cancer; 2022 Jul; 151(2):287-296. PubMed ID: 35285018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
    Wong CK; Lam CL; Wan YF; Fong DY
    BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis.
    Kejela S
    BMC Med Imaging; 2021 Nov; 21(1):162. PubMed ID: 34727883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.
    Ahern CH; Shih YC; Dong W; Parmigiani G; Shen Y
    Br J Cancer; 2014 Oct; 111(8):1542-51. PubMed ID: 25137022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.